Cargando…

Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient

We report on an impressive case of a previously healthy 47-year-old female Caucasian SARS-CoV-2 positive patient who died within 48 h after initial cardiac symptoms. Autopsy revealed necrotizing myocarditis and extensive microthrombosis as the cause of death. The interesting feature of this case is...

Descripción completa

Detalles Bibliográficos
Autores principales: Menter, Thomas, Cueni, Nadine, Gebhard, Eva Caroline, Tzankov, Alexandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358395/
https://www.ncbi.nlm.nih.gov/pubmed/34395562
http://dx.doi.org/10.3389/fcvm.2021.695010
_version_ 1783737330727649280
author Menter, Thomas
Cueni, Nadine
Gebhard, Eva Caroline
Tzankov, Alexandar
author_facet Menter, Thomas
Cueni, Nadine
Gebhard, Eva Caroline
Tzankov, Alexandar
author_sort Menter, Thomas
collection PubMed
description We report on an impressive case of a previously healthy 47-year-old female Caucasian SARS-CoV-2 positive patient who died within 48 h after initial cardiac symptoms. Autopsy revealed necrotizing myocarditis and extensive microthrombosis as the cause of death. The interesting feature of this case is the combination of both myocarditis and extensive localized microthrombosis of cardiac capillaries. Microthrombosis was not present in other organs, and the patient did not show typical features of diffuse alveolar damage in the lungs. Taken together, our morphologic findings illustrate the angiocentric, microangiopathic, thromboinflammatory disease with significant thrombotic diathesis prevalent in COVID-19, which has been previously described in the literature, likely warranting thromboprophylaxis even in oligosymptomatic circumstances. This case also delineates several potential etiologies for microthrombosis, i.e., inflammatory reactions and primary hypercoagulative states. Further systematic analyses on risk stratification for receipt of prophylactic anticoagulation in COVID-19 are urgently required.
format Online
Article
Text
id pubmed-8358395
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83583952021-08-13 Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient Menter, Thomas Cueni, Nadine Gebhard, Eva Caroline Tzankov, Alexandar Front Cardiovasc Med Cardiovascular Medicine We report on an impressive case of a previously healthy 47-year-old female Caucasian SARS-CoV-2 positive patient who died within 48 h after initial cardiac symptoms. Autopsy revealed necrotizing myocarditis and extensive microthrombosis as the cause of death. The interesting feature of this case is the combination of both myocarditis and extensive localized microthrombosis of cardiac capillaries. Microthrombosis was not present in other organs, and the patient did not show typical features of diffuse alveolar damage in the lungs. Taken together, our morphologic findings illustrate the angiocentric, microangiopathic, thromboinflammatory disease with significant thrombotic diathesis prevalent in COVID-19, which has been previously described in the literature, likely warranting thromboprophylaxis even in oligosymptomatic circumstances. This case also delineates several potential etiologies for microthrombosis, i.e., inflammatory reactions and primary hypercoagulative states. Further systematic analyses on risk stratification for receipt of prophylactic anticoagulation in COVID-19 are urgently required. Frontiers Media S.A. 2021-07-29 /pmc/articles/PMC8358395/ /pubmed/34395562 http://dx.doi.org/10.3389/fcvm.2021.695010 Text en Copyright © 2021 Menter, Cueni, Gebhard and Tzankov. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Menter, Thomas
Cueni, Nadine
Gebhard, Eva Caroline
Tzankov, Alexandar
Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
title Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
title_full Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
title_fullStr Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
title_full_unstemmed Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
title_short Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient
title_sort case report: co-occurrence of myocarditis and thrombotic microangiopathy limited to the heart in a covid-19 patient
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358395/
https://www.ncbi.nlm.nih.gov/pubmed/34395562
http://dx.doi.org/10.3389/fcvm.2021.695010
work_keys_str_mv AT menterthomas casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient
AT cueninadine casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient
AT gebhardevacaroline casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient
AT tzankovalexandar casereportcooccurrenceofmyocarditisandthromboticmicroangiopathylimitedtotheheartinacovid19patient